DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Hecker J. et al.
Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
Thromb Haemost 2016;
115: 939-949.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.